Zum Hauptinhalt springen

Press Releases and Ad-hoc Announcements

27. Februar 2022
AH: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
PDF
17. Februar 2022
AH: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini
PDF
15. Februar 2022
PR: Heidelberg Pharma Announces First Patient Dosed with Antibody Targeted Amanitin Conjugate HDP-101 in Multiple Myeloma
PDF
28. Oktober 2021
PR: Heidelberg Pharma Participates at Various Conferences
PDF
07. Oktober 2021
PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2021
PDF
01. Oktober 2021
PR: Heidelberg Pharma AG Announces Adjustment of Guidance
PDF
09. September 2021
PR: Heidelberg Pharma Announces Presentation at H.C. Wainwright 23rd Annual Global Investment Conference and Participation at Various Conferences
PDF
07. September 2021
PR: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with ATAC Candidate HDP-101 in the US
PDF
19. Juli 2021
PR: Paul Ehrlich Institute Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101
PDF
08. Juli 2021
PR: Heidelberg Pharma Reports on First Half-Year 2021
PDF